"NIBE Limited has informed the Exchange regarding the uploading of financial results for the period ended 31-Dec-2025 in Machine Readable Form / Legible copy.''
NIBE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
NIBE Limited has resubmitted its Q3 FY26 and nine-months-ended December 31, 2025 unaudited financial results (standalone and consolidated) to the exchanges. The original filing on February 12, 2026 was made without the ICAI UDIN because the UDIN portal was down; the figures and disclosures remain unchanged — this is purely a procedural resubmission for compliance. On a standalone basis, Q3 FY26 revenue from operations fell sharply to about ₹3,790 lakhs (vs ~₹13,888 lakhs in Q3 FY25), and the company swung to a standalone net loss of ~₹1,338 lakhs versus a profit of ~₹282 lakhs a year ago, with basic EPS of ₹(0.92). On a consolidated basis, Q3 revenue rose to ~₹5,908 lakhs (vs ~₹4,868 lakhs) but the company reported a net loss of ~₹987 lakhs (vs profit of ~₹194 lakhs), with a new 'Aircraft operating expense' line of ~₅₹1,760 lakhs reflecting the newly added Aeronautics segment. The group's nine-month consolidated revenue was ~₹21,494 lakhs with a loss after tax of ~₹1,751 lakhs. Subsidiaries included Nibe Defence & Aerospace, Nibe Automobile, Nibe Technologies, Karmayogi Manufacturing, Nibe Meson Naval, Nibe Space, and step-down Nibe Aeronautics.
Procedurally, this is just a UDIN-related resubmission with no change in numbers, so there is no new information for the market beyond what was already filed on Feb 12, 2026. However, the underlying results are weak — standalone revenue collapsed and the company moved to a loss both standalone and consolidated in Q3 FY26, weighed by a new Aeronautics-segment cost base. Shareholders should track whether the Aeronautics business scales up revenue to absorb the higher operating expenses and whether the defence segment recovers in coming quarters.